CYCN   $0.8148  -0.84% Market Closed

Cyclerion Therapeutics Inc
Total Cash 4.59M
totalCashPerShare 1.824
EBITDA
Total Debt 0.00
quickRatio 3.579
currentRatio 3.678
Total Revenue
debtToEquity
Revenue/Share
ROA -0.46554002
ROE -1.50248
grossProfits
freeCashflow -6.39M
operatingCashflow -11.45M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 1.53M
forwardPE
floatShares 1.23M
sharesOutstanding 2.52M
sharesShort 10.75K
sharesShortPriorMonth 13.07K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.22%
heldPercentInstitutions 0.40%
Short Ratio help_outline 2.56%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 3.491
Price To Book help_outline 0.73
earningsQuarterlyGrowth
netIncomeToCommon -10.47M
trailingEps -4.29%
forwardEps -1.31%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate 4Q 2022
institutionsCount 20
lastUpdated Oct. 16, 2024, 8:11 p.m.